Tool
Supplement comparison tool
Pick up to 4 knowledge base entries and compare their dosage, price, evidence strength and ratings side by side — you can save or share a link to your selection.
Add to comparison (2/4)
| Category | TRT | TRT |
| Evidence strength | Moderate evidence | Strong evidence |
| Evidence Score | 3/5 | 5/5 |
| User rating | 4.4 (142) | 4.7 (102) |
| Typical dose | Studies on gynecomastia used doses from 1 mg to 20 mg per day, with a clear dose-dependent protective effect — a specific regimen for a man outside the oncology context is set individually by the treating physician | Not applicable — this entry describes a safety protocol, not therapy dosing |
| Form | Oral tablets | Monitoring: complete blood count with hematocrit every 3–6 months in the first year, PSA and digital rectal exam before starting and periodically thereafter, lipid panel once a year |
| Average price | ok. 20–40 zł za opakowanie (zależnie od dawki i liczby tabletek) | — |
| Monthly cost | ok. 20–50 zł/miesiąc przy typowym schemacie, plus koszt wizyt i badań kontrolnych zlecanych przez lekarza | — |
| Time to effects | In gynecomastia studies, the protective effect was assessed at 6 months (Fradet et al.) and at 48 weeks (Boccardo et al.) of regular use alongside the hormonal therapy creating the risk; for hormonal-axis support, time to effect is not as well characterized in dedicated studies as it is for clomiphene. | Not applicable — monitoring is an ongoing process that continues throughout the entire course of therapy. |
| Who it's for | Men with gynecomastia related to hormonal therapy (including, occasionally, TRT) or an estrogen-androgen imbalance, under a physician's care | All patients starting or continuing TRT |